Clinical Trial Failure Isn’t an Inevitable Risk—It’s Insurable and Opening the Door to New Investors
Clinical trial failure insurance is turning biotech’s most costly risk into a manageable asset, opening new pathways for funding and innovation.
Natalie Marquess, ARM, CIC, CRM
Advertisement
Director - Business Development, Life Sciences at Aon
Articles by Natalie Marquess, ARM, CIC, CRM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
2
2025 SCRS Global Site Solutions Summit: Best Practices for Building Strong Site Partnerships and Choosing the Right Technology
3
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
4
ACT Brief Weekly Recap: AI Monitoring, Biotech Scaling, and Site Interoperability Lead This Week’s Top Stories
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
